United Kingdom · Question · Written question
UIN 9850
Rare Diseases: Drugs
Introduced
16 January 2024
Last action
23 January 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
23 January 2024
Summary
To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential impact of the (a) methods and (b) processes used by the National Institute for Health and Care Excellence on access to medicines for patient
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
16 January 2024
Written question
To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential impact of the (a) methods and (b) processes used by the National Institute for Health and Care Excellence on access to medicines for patient
Source: Commons
23 January 2024
Answer
The National Institute for Health and Care Excellence (NICE) can recommend most rare disease medicines that it appraises through the technology appraisal programme for some or all eligible patients. NICE has no current plans to undertake a modular update ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-01-16/9850
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1682489
- uk · wq-1682489 · source updated 23 January 2024